↓ Skip to main content

Dove Medical Press

Clinical Efficacy of Intravenous Immunoglobulin for BK Polyomavirus-Associated Nephropathy After Living Kidney Transplantation

Overview of attention for article published in Therapeutics and Clinical Risk Management, October 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
16 Mendeley
Title
Clinical Efficacy of Intravenous Immunoglobulin for BK Polyomavirus-Associated Nephropathy After Living Kidney Transplantation
Published in
Therapeutics and Clinical Risk Management, October 2020
DOI 10.2147/tcrm.s273388
Pubmed ID
Authors

Soichi Matsumura, Taigo Kato, Ayumu Taniguchi, Masataka Kawamura, Shigeaki Nakazawa, Tomoko Namba-Hamano, Toyofumi Abe, Norio Nonomura, Ryoichi Imamura

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 25%
Researcher 3 19%
Student > Bachelor 1 6%
Student > Master 1 6%
Student > Ph. D. Student 1 6%
Other 2 13%
Unknown 4 25%
Readers by discipline Count As %
Medicine and Dentistry 7 44%
Immunology and Microbiology 2 13%
Neuroscience 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unknown 5 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2023.
All research outputs
#8,541,797
of 25,387,668 outputs
Outputs from Therapeutics and Clinical Risk Management
#462
of 1,323 outputs
Outputs of similar age
#178,241
of 432,252 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#8
of 13 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,252 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.